Ingevity (NGVT)
(Delayed Data from NYSE)
$45.15 USD
+0.71 (1.60%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $45.14 -0.01 (-0.02%) 6:48 PM ET
3-Hold of 5 3
B Value C Growth F Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$45.15 USD
+0.71 (1.60%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $45.14 -0.01 (-0.02%) 6:48 PM ET
3-Hold of 5 3
B Value C Growth F Momentum C VGM
Zacks News
4 Stocks to Buy From the Promising Chemical Specialty Industry
by Anindya Barman
The Zacks Chemicals Specialty industry is poised to benefit from higher demand across major end-use markets. LTHM, DQ, NGVT and HWKN are set to gain from the favorable industry fundamentals and strategic actions to counter cost inflation.
Why You Should Add Ingevity (NGVT) Stock to Your Portfolio
by Zacks Equity Research
Ingevity (NGVT) rides on solid demand and higher selling prices in engineered polymers and industrial specialties businesses and its growth actions.
Wall Street Analysts Think Ingevity (NGVT) Could Surge 25%: Read This Before Placing a Bet
by Zacks Equity Research
The consensus price target hints at a 25.3% upside potential for Ingevity (NGVT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Why Ingevity (NGVT) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Is Mercer International (MERC) Outperforming Other Basic Materials Stocks This Year?
by Zacks Equity Research
Here is how Mercer International (MERC) and Ingevity (NGVT) have performed compared to their sector so far this year.
Ingevity's (NGVT) Earnings and Sales Top Estimates in Q2
by Zacks Equity Research
Ingevity (NGVT) benefits from actions to increase prices to offset inflationary cost pressures in Q2.
How Much Upside is Left in Ingevity (NGVT)? Wall Street Analysts Think 31%
by Zacks Equity Research
The mean of analysts' price targets for Ingevity (NGVT) points to a 30.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Ingevity (NGVT) Just Reclaimed the 200-Day Moving Average
by Zacks Equity Research
Good things could be on the horizon when a stock surpasses the 200-day simple moving average. How should investors react?
Ingevity (NGVT) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Ingevity (NGVT) delivered earnings and revenue surprises of 2.98% and 3.30%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Analyst Blog Highlights Ingevity, Cabot, Livent, Albemarle and Air Products and Chemicals
by Zacks Equity Research
Ingevity, Cabot, Livent, Albemarle and Air Products and Chemicals are part of Zacks top Analyst Blog.
Can Ingevity (NGVT) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
Ingevity (NGVT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Intel's (INTC) Q2 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Intel (INTC) misses second-quarter revenue and earnings estimates due to a decline in revenues of Client Computing Group and Datacenter and AI Group.
5 Chemical Stocks Set to Pull Off a Beat This Earnings Season
by Anindya Barman
Strong end-market demand and benefits of self-help actions are likely to have been reflected in the performance of Ingevity (NGVT), Cabot (CBT), Livent (LTHM), Albemarle (ALB) and Air Products (APD).
Minerals Technologies (MTX) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Minerals Technologies (MTX) delivered earnings and revenue surprises of 2.74% and 5.34%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Silicon Motion (SIMO) Q2 Earnings Beat Estimates, Revenues Lag
by Zacks Equity Research
Despite healthy earnings growth due to solid demand trends, Silicon Motion Technology (SIMO) misses second-quarter revenue estimates.
Element Solutions (ESI) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Element Solutions (ESI) delivered earnings and revenue surprises of 2.70% and 0.10%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Vale (VALE) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Vale's (VALE) second-quarter 2022 results are likely to reflect the impact of lower iron ore, copper and nickel prices as well as higher diesel and freight costs.
Ingevity (NGVT) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Ingevity (NGVT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Nexa Resources (NEXA) to Report Q2 Earnings: What's in Store?
by Zacks Equity Research
Nexa Resources' (NEXA) second-quarter 2022 results are likely to reflect lower metal sales, higher production levels and inflated operating costs.
Here's Why You Should Buy Ingevity (NGVT) Stock Right Now
by Zacks Equity Research
Ingevity (NGVT) rides on solid demand and higher selling prices in engineered polymers and industrial specialties businesses and its growth actions.
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Ingevity (NGVT) Gains on Strong Demand, Capacity Expansion
by Zacks Equity Research
Ingevity (NGVT) benefits from strength in its engineered polymers and industrial specialties businesses and actions to drive growth.
Ingevity (NGVT) Up 10.6% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Ingevity (NGVT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why Ingevity (NGVT) is a Strong Growth Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Is Ingevity (NGVT) a Suitable Stock for Value Investors Now?
by Zacks Equity Research
Let's put Ingevity Corporation (NGVT) stock into this equation and find out if it is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.